Healthcare entity
Every one of those 2 sits in a single category, regulation. Center for Drug Evaluation and Research is most often covered alongside Tracy Beth Hoeg, which appears in 2 of these 2 stories. The 190-day window averages about 0.1 stories each week.
Last mentioned: 2d ago
Entity pulse
Coverage balance Negative coverage leads. Negative coverage exceeds positive coverage by 50 percentage points.
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
Every one of those 2 sits in a single category, regulation. Center for Drug Evaluation and Research is most often covered alongside Tracy Beth Hoeg, which appears in 2 of these 2 stories. The 190-day window averages about 0.1 stories each week. Each story carries 2 original sources on average, compared with 3.4 for the broader beat in this window. The average consequence score is 6, matching the 6 beat baseline for this window. We currently track 2 Healthcare stories that mention Center for Drug Evaluation and Research, published between March 4, 2026 and September 9, 2026.
Computed from the 2 stories linked to this entity, with beat comparisons drawn from all 1089 Healthcare stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering Center for Drug Evaluation and Research. Shared-story counts are live from our verified record — not editorial picks.
HHS fills four senior FDA roles
The Department of Health and Human Services announced permanent directors for the FDA's drug, vaccine and biologics, and tobacco centers, along with a fourth senior position.
Hoeg departs CDER
Dr. Tracy Beth Hoeg said she was fired from the Center for Drug Evaluation and Research; Davis began serving in an acting role.
Davis returns to FDA
Michael Davis rejoined the agency as a deputy director after working at a nonprofit pursuing psychedelic drug development.
FDA gains stability as HHS fills four senior roles, with permanent directors for drug, vaccine and tobacco centers. The moves follow months of upheaval and could reshape regulatory timelines, safety oversight, and public health policy.
A high-ranking FDA official is reportedly attempting to recruit Dr. Tracy Beth Hoeg, a vocal advocate for stricter antidepressant warnings, to a key agency role. The move signals a potential shift in how the FDA evaluates long-term psychiatric drug risks and has raised internal concerns regarding hiring protocols.
Center for Drug Evaluation and Research is linked from 2 stories on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.
